Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and Radiation for Locally Advanced Vulvar Cancer
NCT00068406Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jan 2005
- Primary completion
- Dec 2010
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in vulvar squamous cell carcinoma (VSCC), sponsored by GOG Foundation. Started Jan 2005; status: completed.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
vulvar squamous cell carcinoma (VSCC)
Beyond the preview
Go deeper on NCT00068406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068406.